IDXX Earnings
Latest Revenue1.2B
Latest Net Income338.4M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $4.29 | 1.2B | 338.4M | +9.7% | +17.2% |
| Q1 2026 | $3.50 | 1.1B | 278.4M | +14.3% | +17.4% |
| Q4 2025 | $3.11 | 1.1B | 248.2M | +14.3% | +17.8% |
| Q3 2025 | $3.43 | 1.1B | 274.6M | +13.3% | +21.2% |
| Q2 2025 | $3.66 | 1.1B | 294.0M | +10.6% | +48.8% |
| Q1 2025 | $2.98 | 998.4M | 242.7M | +3.6% | +4.9% |
| Q4 2024 | $2.64 | 954.3M | 216.1M | +5.8% | +12.8% |
| Q3 2024 | $2.83 | 975.5M | 232.8M | +6.6% | +11.0% |
| Q2 2024 | $2.46 | 1.0B | 203.3M | — | — |
| Q1 2024 | $2.84 | 964.1M | 235.6M | — | — |
| Q4 2023 | $2.34 | 901.6M | 194.5M | — | — |
| Q3 2023 | $2.55 | 915.5M | 212.2M | — | — |
Idexx Laboratories (IDXX) — Earnings